Covid-19 May Accelerate Volume of Ophthalmology Procedures In ASCs

“Trends were already shifting out of the hospital OR over to ambulatory surgery centers and will more than likely be accelerated because of this pandemic,” Nancy Lurker, EyePoint Pharmaceuticals president and CEO, said during the event. Post pandemic patients will be looking to minimise potential virus exposure. As a result ASC s will be more appealing to patients than Hospitals. The ASC setting are also likely to be having better handling of the high volume routine procedures which are postpond due to the pandemic, according to Laurent Attias, Alcon senior vice president of corporate development strategy, business development and licensing, and mergers and acquisitions.

For more information:

Related Articles

Share on facebook
Share on whatsapp
Share on email